vs
Side-by-side financial comparison of Claritev Corp (CTEV) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $148.5M, roughly 1.7× OPKO HEALTH, INC.). OPKO HEALTH, INC. runs the higher net margin — -21.1% vs -32.7%, a 11.6% gap on every dollar of revenue. On growth, Claritev Corp posted the faster year-over-year revenue change (6.2% vs -19.2%). Claritev Corp produced more free cash flow last quarter ($36.4M vs $-28.6M). Over the past eight quarters, Claritev Corp's revenue compounded faster (2.5% CAGR vs -7.5%).
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
CTEV vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $246.6M | $148.5M |
| Net Profit | $-80.6M | $-31.3M |
| Gross Margin | — | 43.1% |
| Operating Margin | -3.1% | -25.8% |
| Net Margin | -32.7% | -21.1% |
| Revenue YoY | 6.2% | -19.2% |
| Net Profit YoY | 41.6% | -322.8% |
| EPS (diluted) | $-4.88 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $246.6M | $148.5M | ||
| Q3 25 | $246.0M | $151.7M | ||
| Q2 25 | $241.6M | $156.8M | ||
| Q1 25 | $231.3M | $150.0M | ||
| Q4 24 | $232.1M | $183.6M | ||
| Q3 24 | $230.5M | $173.6M | ||
| Q2 24 | $233.5M | $182.2M | ||
| Q1 24 | $234.5M | $173.7M |
| Q4 25 | $-80.6M | $-31.3M | ||
| Q3 25 | $-69.8M | $21.6M | ||
| Q2 25 | $-62.6M | $-148.4M | ||
| Q1 25 | $-71.3M | $-67.6M | ||
| Q4 24 | $-138.0M | $14.0M | ||
| Q3 24 | $-391.4M | $24.9M | ||
| Q2 24 | $-576.7M | $-10.3M | ||
| Q1 24 | $-539.7M | $-81.8M |
| Q4 25 | — | 43.1% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 31.5% | ||
| Q1 25 | — | 28.4% | ||
| Q4 24 | — | 46.1% | ||
| Q3 24 | — | 23.1% | ||
| Q2 24 | — | 28.4% | ||
| Q1 24 | — | 24.2% |
| Q4 25 | -3.1% | -25.8% | ||
| Q3 25 | 4.1% | 31.7% | ||
| Q2 25 | 6.9% | -38.3% | ||
| Q1 25 | 4.2% | -44.8% | ||
| Q4 24 | -17.8% | -18.0% | ||
| Q3 24 | -146.7% | 8.2% | ||
| Q2 24 | -224.4% | -33.9% | ||
| Q1 24 | -207.4% | -41.2% |
| Q4 25 | -32.7% | -21.1% | ||
| Q3 25 | -28.4% | 14.3% | ||
| Q2 25 | -25.9% | -94.7% | ||
| Q1 25 | -30.8% | -45.1% | ||
| Q4 24 | -59.4% | 7.6% | ||
| Q3 24 | -169.8% | 14.3% | ||
| Q2 24 | -247.0% | -5.7% | ||
| Q1 24 | -230.1% | -47.1% |
| Q4 25 | $-4.88 | $-0.04 | ||
| Q3 25 | $-4.23 | $0.03 | ||
| Q2 25 | $-3.81 | $-0.19 | ||
| Q1 25 | $-4.38 | $-0.10 | ||
| Q4 24 | $-8.49 | $0.02 | ||
| Q3 24 | $-24.25 | $0.03 | ||
| Q2 24 | $-35.78 | $-0.01 | ||
| Q1 24 | $-33.40 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $16.8M | $364.4M |
| Total DebtLower is stronger | $4.6B | $344.0M |
| Stockholders' EquityBook value | $-173.9M | $1.3B |
| Total Assets | $4.9B | $1.9B |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.8M | $364.4M | ||
| Q3 25 | $39.2M | $412.0M | ||
| Q2 25 | $56.4M | $267.3M | ||
| Q1 25 | $23.1M | $428.8M | ||
| Q4 24 | $16.8M | $426.6M | ||
| Q3 24 | $86.6M | $400.1M | ||
| Q2 24 | $48.8M | $40.6M | ||
| Q1 24 | $58.7M | $75.6M |
| Q4 25 | $4.6B | $344.0M | ||
| Q3 25 | $4.5B | $344.2M | ||
| Q2 25 | $4.5B | $343.3M | ||
| Q1 25 | $4.5B | $439.2M | ||
| Q4 24 | $4.5B | $437.2M | ||
| Q3 24 | $4.5B | $441.0M | ||
| Q2 24 | $4.5B | $201.9M | ||
| Q1 24 | $4.5B | $350.1M |
| Q4 25 | $-173.9M | $1.3B | ||
| Q3 25 | $-101.8M | $1.3B | ||
| Q2 25 | $-39.9M | $1.3B | ||
| Q1 25 | $14.8M | $1.3B | ||
| Q4 24 | $84.0M | $1.4B | ||
| Q3 24 | $207.6M | $1.4B | ||
| Q2 24 | $603.4M | $1.4B | ||
| Q1 24 | $1.2B | $1.3B |
| Q4 25 | $4.9B | $1.9B | ||
| Q3 25 | $5.0B | $2.0B | ||
| Q2 25 | $5.1B | $2.0B | ||
| Q1 25 | $5.1B | $2.1B | ||
| Q4 24 | $5.2B | $2.2B | ||
| Q3 24 | $5.3B | $2.3B | ||
| Q2 24 | $5.7B | $2.0B | ||
| Q1 24 | $6.4B | $2.0B |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | 304.87× | 0.33× | ||
| Q4 24 | 53.67× | 0.32× | ||
| Q3 24 | 21.73× | 0.31× | ||
| Q2 24 | 7.48× | 0.14× | ||
| Q1 24 | 3.85× | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.3M | $-25.9M |
| Free Cash FlowOCF − Capex | $36.4M | $-28.6M |
| FCF MarginFCF / Revenue | 14.8% | -19.3% |
| Capex IntensityCapex / Revenue | 12.1% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.3M | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.3M | $-25.9M | ||
| Q3 25 | $19.9M | $-34.6M | ||
| Q2 25 | $61.2M | $-83.4M | ||
| Q1 25 | $-30.1M | $-34.6M | ||
| Q4 24 | $-33.4M | $-44.4M | ||
| Q3 24 | $72.8M | $-77.1M | ||
| Q2 24 | $18.5M | $-26.4M | ||
| Q1 24 | $49.7M | $-35.6M |
| Q4 25 | $36.4M | $-28.6M | ||
| Q3 25 | $-16.3M | $-37.8M | ||
| Q2 25 | $36.6M | $-86.7M | ||
| Q1 25 | $-68.9M | $-37.7M | ||
| Q4 24 | $-63.8M | $-49.8M | ||
| Q3 24 | $41.1M | $-85.0M | ||
| Q2 24 | $-7.0M | $-33.7M | ||
| Q1 24 | $19.2M | $-40.0M |
| Q4 25 | 14.8% | -19.3% | ||
| Q3 25 | -6.6% | -24.9% | ||
| Q2 25 | 15.2% | -55.3% | ||
| Q1 25 | -29.8% | -25.2% | ||
| Q4 24 | -27.5% | -27.1% | ||
| Q3 24 | 17.8% | -49.0% | ||
| Q2 24 | -3.0% | -18.5% | ||
| Q1 24 | 8.2% | -23.0% |
| Q4 25 | 12.1% | 1.8% | ||
| Q3 25 | 14.7% | 2.1% | ||
| Q2 25 | 10.2% | 2.1% | ||
| Q1 25 | 16.8% | 2.1% | ||
| Q4 24 | 13.1% | 2.9% | ||
| Q3 24 | 13.8% | 4.6% | ||
| Q2 24 | 10.9% | 4.0% | ||
| Q1 24 | 13.0% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.60× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.17× | ||
| Q3 24 | — | -3.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTEV
Segment breakdown not available.
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
